Login Register Cart 0
Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review

Author(s): Konstantin Yenkoyan*, Meri Mkhitaryan and Geir Bjørklund*

Volume 31, Issue 17, 2024

Published on: 10 January, 2024

Page: [2345 - 2360] Pages: 16

DOI: 10.2174/0109298673252471231121045529

Price: $65

Abstract

Existing evidence indicates that environmental factors might contribute up to 50% of the variance in autism spectrum disorder (ASD) risk. This structured narrative review offers a comprehensive synthesis of current knowledge on environmental risk factors in ASD, including evaluation of conflicting evidence, exploration of underlying mechanisms, and suggestions for future research directions. Analysis of diverse epidemiological investigations indicates that certain environmental factors, including advanced parental age, preterm birth, delivery complications, and exposure to toxic metals, drugs, air pollutants, and endocrine-disrupting chemicals, are linked to an increased ASD risk through various mechanisms such as oxidative stress, inflammation, hypoxia, and its consequences, changes in neurotransmitters, disruption of signaling pathways and some others. On the other hand, pregnancy-related factors such as maternal diabetes, maternal obesity, and caesarian section show a weaker association with ASD risk. At the same time, other environmental factors, such as vaccination, maternal smoking, or alcohol consumption, are not linked to the risk of ASD. Regarding nutritional elements data are inconclusive. These findings highlight the significance of environmental factors in ASD etiology and emphasize that more focused research is needed to target the risk factors of ASD. Environmental interventions targeting modifiable risk factors might offer promising avenues for ASD prevention and treatment.

« Previous Next »
[1]
Kanner, L. Follow-up study of eleven autistic children originally reported in 1943. J. Autism Child. Schizophr., 1971, 1(2), 119-145.
[http://dx.doi.org/10.1007/BF01537953] [PMID: 5172388]
[2]
Vahnia VN. Diagnostic and statistical manual of mental disorders. A quick glance. J. Psyc. India, 2013, 55(3), 220.
[3]
Christensen, D.L.; Baio, J.; Braun, K.V.N.; Bilder, D.; Charles, J.; Constantino, J.N.; Daniels, J.; Durkin, M.S.; Fitzgerald, R.T.; Kurzius-Spencer, M. Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network. MMWR Surveill. Summ., 2012, 6503a1.
[http://dx.doi.org/10.15585/mmwr.ss6503a1] [PMID: 27031587]
[4]
Croen, L.A.; Zerbo, O.; Qian, Y.; Massolo, M.L.; Rich, S.; Sidney, S.; Kripke, C. The health status of adults on the autism spectrum. Autism, 2015, 19(7), 814-823.
[http://dx.doi.org/10.1177/1362361315577517] [PMID: 25911091]
[5]
Matson, J.L.; Cervantes, P.E. Commonly studied comorbid psychopathologies among persons with autism spectrum disorder. Res. Dev. Disabil., 2014, 35(5), 952-962.
[http://dx.doi.org/10.1016/j.ridd.2014.02.012] [PMID: 24629541]
[6]
Devlin, B.; Scherer, S.W. Genetic architecture in autism spectrum disorder. Curr. Opin. Genet. Dev., 2012, 22(3), 229-237.
[http://dx.doi.org/10.1016/j.gde.2012.03.002] [PMID: 22463983]
[7]
Szatmari, P.; Chawarska, K.; Dawson, G.; Georgiades, S.; Landa, R.; Lord, C.; Messinger, D.S.; Thurm, A.; Halladay, A. Prospective longitudinal studies of infant siblings of children with autism: Lessons learned and future directions. J. Am. Acad. Child Adolesc. Psychiatry, 2016, 55(3), 179-187.
[http://dx.doi.org/10.1016/j.jaac.2015.12.014] [PMID: 26903251]
[8]
Zwaigenbaum, L.; Bryson, S. E.; Brian, J.; Smith, I. M.; Roberts, W.; Szatmari, P.; Roncadin, C.; Garon, N.; Vaillancourt, T. Stability of diagnostic assessment for autism spectrum disorder between 18 and 36 months in a high-risk cohort. Autism Res., 2016, 9(7), 790-800.
[http://dx.doi.org/10.1002/aur.1585]
[9]
Hallmayer, J.; Cleveland, S.; Torres, A.; Phillips, J.; Cohen, B.; Torigoe, T.; Miller, J.; Fedele, A.; Collins, J.; Smith, K.; Lotspeich, L.; Croen, L.A.; Ozonoff, S.; Lajonchere, C.; Grether, J.K.; Risch, N. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry, 2011, 68(11), 1095-1102.
[http://dx.doi.org/10.1001/archgenpsychiatry.2011.76] [PMID: 21727249]
[10]
Risch, N.; Hoffmann, T.J.; Anderson, M.; Croen, L.A.; Grether, J.K.; Windham, G.C. Familial recurrence of autism spectrum disorder: Evaluating genetic and environmental contributions. Am. J. Psychiatry, 2014, 171(11), 1206-1213.
[http://dx.doi.org/10.1176/appi.ajp.2014.13101359] [PMID: 24969362]
[11]
Zeidan, J.; Fombonne, E.; Scorah, J.; Ibrahim, A.; Durkin, M.S.; Saxena, S.; Yusuf, A.; Shih, A.; Elsabbagh, M. Global prevalence of autism: A systematic review update. Autism Res., 2022, 15(5), 778-790.
[http://dx.doi.org/10.1002/aur.2696] [PMID: 35238171]
[12]
Kim, Y.S.; Leventhal, B.L.; Koh, Y.J.; Fombonne, E.; Laska, E.; Lim, E.C.; Cheon, K.A.; Kim, S.J.; Kim, Y.K.; Lee, H.; Song, D.H.; Grinker, R.R. Prevalence of autism spectrum disorders in a total population sample. Am. J. Psychiatry, 2011, 168(9), 904-912.
[http://dx.doi.org/10.1176/appi.ajp.2011.10101532] [PMID: 21558103]
[13]
West, E.A.; Travers, J.C.; Kemper, T.D.; Liberty, L.M.; Cote, D.L.; McCollow, M.M.; Stansberry Brusnahan, L.L. Racial and ethnic diversity of participants in research supporting evidence-based practices for learners with autism spectrum disorder. J. Spec. Educ., 2016, 50(3), 151-163.
[http://dx.doi.org/10.1177/0022466916632495]
[14]
Werling, D.M.; Geschwind, D.H. Sex differences in autism spectrum disorders. Curr. Opin. Neurol., 2013, 26(2), 146-153.
[http://dx.doi.org/10.1097/WCO.0b013e32835ee548] [PMID: 23406909]
[15]
CDC. Autism and Developmental Disabilities Monitoring (ADDM) Network. Available from:https://www.cdc.gov/ncbddd/autism/addm.html (Accessed Mar 5, 2023).
[16]
CDC. Data and Statistics on Autism Spectrum Disorder., Available from:https://www.cdc.gov/ncbddd/autism/data.html (Accessed May 7, 2021)
[17]
CDC. Data and Statistics on Autism Spectrum Disorder. Available from:https://www.cdc.gov/ncbddd/autism/data.html (Accessed Mar 5, 2023).
[18]
Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators. Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill. Summ., 2007, 56(1), 12-28.
[19]
Buescher, A.V.S.; Cidav, Z.; Knapp, M.; Mandell, D.S. Costs of autism spectrum disorders in the united kingdom and the united states. JAMA Pediatr., 2014, 168(8), 721.
[http://dx.doi.org/10.1001/jamapediatrics.2014.210]
[20]
King, B.H. Psychiatric comorbidities in neurodevelopmental disorders. Curr. Opin. Neurol., 2016, 29(2), 113-117.
[http://dx.doi.org/10.1097/WCO.0000000000000299] [PMID: 26840045]
[21]
Lyall, K.; Croen, L.; Daniels, J.; Fallin, M. D.; Ladd-Acosta, C.; Lee, B. K.; Park, B. Y.; Snyder, N. W.; Schendel, D.; Volk, H. The changing epidemiology of autism spectrum disorders. Annu. Rev. Public Health, 2016, 38, 81-102.
[22]
Schendel, D.E.; Overgaard, M.; Christensen, J.; Hjort, L.; Jørgensen, M.; Vestergaard, M.; Parner, E.T. Association of psychiatric and neurologic comorbidity with mortality among persons with autism spectrum disorder in a danish population. JAMA Pediatr., 2016, 170(3), 243-250.
[http://dx.doi.org/10.1001/jamapediatrics.2015.3935] [PMID: 26752506]
[23]
Larsson, H.; Boman, M.; Hirvikoski, T.; Bölte, S.; Mittendorfer-Rutz, E.; Lichtenstein, P. Premature mortality in autism spectrum disorder. Br. J. Psychiatry, 2015, 2015, 160192.
[http://dx.doi.org/10.1192/bjp.bp.114.160192] [PMID: 26541693]
[24]
Shimabukuro, T.T.; Grosse, S.D.; Rice, C. Medical expenditures for children with an autism spectrum disorder in a privately insured population. J. Autism Dev. Disord., 2008, 38(3), 546-552.
[http://dx.doi.org/10.1007/s10803-007-0424-y] [PMID: 17690969]
[25]
Cidav, Z.; Marcus, S.C.; Mandell, D.S. Implications of childhood autism for parental employment and earnings. Pediatrics, 2012, 129(4), 617-623.
[http://dx.doi.org/10.1542/peds.2011-2700] [PMID: 22430453]
[26]
Leigh, J.P.; Du, J. Brief report: Forecasting the economic burden of autism in 2015 and 2025 in the united states. J. Autism Dev. Disord., 2015, 45(12), 4135-4139.
[http://dx.doi.org/10.1007/s10803-015-2521-7] [PMID: 26183723]
[27]
Tick, B.; Bolton, P.; Happé, F.; Rutter, M.; Rijsdijk, F. Heritability of autism spectrum disorders: A meta-analysis of twin studies. J. Child Psychol. Psychiatry, 2016, 57(5), 585-595.
[http://dx.doi.org/10.1111/jcpp.12499] [PMID: 26709141]
[28]
Guinchat, V.; Thorsen, P.; Laurent, C.; Cans, C.; Bodeau, N.; Cohen, D. Pre-, peri- and neonatal risk factors for autism. Acta Obstet. Gynecol. Scand., 2012, 91(3), 287-300.
[http://dx.doi.org/10.1111/j.1600-0412.2011.01325.x] [PMID: 22085436]
[29]
Kolevzon, A.; Gross, R.; Reichenberg, A. Prenatal and perinatal risk factors for autism: A review and integration of findings. Arch. Pediatr. Adolesc. Med., 2007, 161(4), 326-333.
[http://dx.doi.org/10.1001/archpedi.161.4.326] [PMID: 17404128]
[30]
Gardener, H.; Spiegelman, D.; Buka, S.L. Prenatal risk factors for autism: Comprehensive meta-analysis. Br. J. Psychiatry, 2009, 195(1), 7-14.
[http://dx.doi.org/10.1192/bjp.bp.108.051672] [PMID: 19567888]
[31]
Gardener, H.; Spiegelman, D.; Buka, S.L. Perinatal and neonatal risk factors for autism: A comprehensive meta-analysis. Pediatrics, 2011, 128(2), 344-355.
[http://dx.doi.org/10.1542/peds.2010-1036] [PMID: 21746727]
[32]
Sandin, S.; Hultman, C.M.; Kolevzon, A.; Gross, R.; MacCabe, J.H.; Reichenberg, A. Advancing maternal age is associated with increasing risk for autism: A review and meta-analysis. J. Am. Acad. Child Adolesc. Psychiatry, 2012, 51(5), 477-486.e1.
[http://dx.doi.org/10.1016/j.jaac.2012.02.018] [PMID: 22525954]
[33]
Idring, S.; Magnusson, C.; Lundberg, M.; Ek, M.; Rai, D.; Svensson, A.C.; Dalman, C.; Karlsson, H.; Lee, B.K. Parental age and the risk of autism spectrum disorders: Findings from a Swedish population-based cohort. Int. J. Epidemiol., 2014, 43(1), 107-115.
[http://dx.doi.org/10.1093/ije/dyt262] [PMID: 24408971]
[34]
Wu, S.; Wu, F.; Ding, Y.; Hou, J.; Bi, J.; Zhang, Z. Advanced parental age and autism risk in children: A systematic review and meta-analysis. Acta Psychiatr. Scand., 2017, 135(1), 29-41.
[http://dx.doi.org/10.1111/acps.12666] [PMID: 27858958]
[35]
Sandin, S.; Schendel, D.; Magnusson, P.; Hultman, C.; Surén, P.; Susser, E.; Grønborg, T.; Gissler, M.; Gunnes, N.; Gross, R.; Henning, M.; Bresnahan, M.; Sourander, A.; Hornig, M.; Carter, K.; Francis, R.; Parner, E.; Leonard, H.; Rosanoff, M.; Stoltenberg, C.; Reichenberg, A. Autism risk associated with parental age and with increasing difference in age between the parents. Mol. Psychiatry, 2016, 21(5), 693-700.
[http://dx.doi.org/10.1038/mp.2015.70] [PMID: 26055426]
[36]
Shelton, J.F.; Tancredi, D.J.; Hertz-Picciotto, I. Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res., 2010, 3(1), n/a.
[http://dx.doi.org/10.1002/aur.116] [PMID: 20143326]
[37]
Cheslack-Postava, K.; Liu, K.; Bearman, P.S. Closely spaced pregnancies are associated with increased odds of autism in California sibling births. Pediatrics, 2011, 127(2), 246-253.
[http://dx.doi.org/10.1542/peds.2010-2371] [PMID: 21220394]
[38]
Cheslack-Postava, K.; Suominen, A.; Jokiranta, E.; Lehti, V.; McKeague, I.W.; Sourander, A.; Brown, A.S. Increased risk of autism spectrum disorders at short and long interpregnancy intervals in Finland. J. Am. Acad. Child Adolesc. Psychiatry, 2014, 53(10), 1074-1081.e4.
[http://dx.doi.org/10.1016/j.jaac.2014.06.009] [PMID: 25245351]
[39]
Zerbo, O.; Yoshida, C.; Gunderson, E.P.; Dorward, K.; Croen, L.A. Interpregnancy interval and risk of autism spectrum disorders. Pediatrics, 2015, 136(4), 651-657.
[http://dx.doi.org/10.1542/peds.2015-1099] [PMID: 26371204]
[40]
Gunnes, N.; Surén, P.; Bresnahan, M.; Hornig, M.; Lie, K.K.; Lipkin, W.I.; Magnus, P.; Nilsen, R.M.; Reichborn-Kjennerud, T.; Schjølberg, S.; Susser, E.S.; Øyen, A.S.; Stoltenberg, C. Interpregnancy interval and risk of autistic disorder. Epidemiology, 2013, 24(6), 906-912.
[http://dx.doi.org/10.1097/01.ede.0000434435.52506.f5] [PMID: 24045716]
[41]
Durkin, M.S.; DuBois, L.A.; Maenner, M.J. Inter-pregnancy intervals and the risk of autism spectrum disorder: Results of a population-based study. J. Autism Dev. Disord., 2015, 45(7), 2056-2066.
[http://dx.doi.org/10.1007/s10803-015-2368-y] [PMID: 25636677]
[42]
Coo, H.; Ouellette-Kuntz, H.; Lam, Y.M.; Brownell, M.; Flavin, M.P.; Roos, L.L. The association between the interpregnancy interval and autism spectrum disorder in a Canadian cohort. Can. J. Public Health, 2015, 106(2), e36-e42.
[http://dx.doi.org/10.17269/CJPH.106.4667] [PMID: 25955670]
[43]
Conde-Agudelo, A.; Rosas-Bermúdez, A.; Kafury-Goeta, A.C. Birth spacing and risk of adverse perinatal outcomes: A meta-analysis. JAMA, 2006, 295(15), 1809-1823.
[http://dx.doi.org/10.1001/jama.295.15.1809] [PMID: 16622143]
[44]
Lee, B.K.; Magnusson, C.; Gardner, R.M.; Blomström, Å.; Newschaffer, C.J.; Burstyn, I.; Karlsson, H.; Dalman, C. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav. Immun., 2015, 44, 100-105.
[http://dx.doi.org/10.1016/j.bbi.2014.09.001] [PMID: 25218900]
[45]
Zerbo, O.; Qian, Y.; Yoshida, C.; Grether, J.K.; Van de Water, J.; Croen, L.A. Maternal infection during pregnancy and autism spectrum disorders. J. Autism Dev. Disord., 2015, 45(12), 4015-4025.
[http://dx.doi.org/10.1007/s10803-013-2016-3] [PMID: 24366406]
[46]
Choi, G.B.; Yim, Y.S.; Wong, H.; Kim, S.; Kim, H.; Kim, S.V.; Hoeffer, C.A.; Littman, D.R.; Huh, J.R. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science, 2016, 351(6276), 933-939.
[http://dx.doi.org/10.1126/science.aad0314] [PMID: 26822608]
[47]
Braunschweig, D.; Van de Water, J. Maternal autoantibodies in autism. Arch. Neurol., 2012, 69(6), 693-699.
[http://dx.doi.org/10.1001/archneurol.2011.2506] [PMID: 22689191]
[48]
Mazina, V.; Gerdts, J.; Trinh, S.; Ankenman, K.; Ward, T.; Dennis, M.Y.; Girirajan, S.; Eichler, E.E.; Bernier, R. Epigenetics of autism-related impairment: copy number variation and maternal infection. J. Dev. Behav. Pediatr., 2015, 36(2), 61-67.
[http://dx.doi.org/10.1097/DBP.0000000000000126] [PMID: 25629966]
[49]
Croen, L.A.; Grether, J.K.; Yoshida, C.K.; Odouli, R.; Van de Water, J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Arch. Pediatr. Adolesc. Med., 2005, 159(2), 151-157.
[http://dx.doi.org/10.1001/archpedi.159.2.151] [PMID: 15699309]
[50]
Atladóttir, H.Ó.; Pedersen, M.G.; Thorsen, P.; Mortensen, P.B.; Deleuran, B.; Eaton, W.W.; Parner, E.T. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics, 2009, 124(2), 687-694.
[http://dx.doi.org/10.1542/peds.2008-2445] [PMID: 19581261]
[51]
Kohane, I.S.; McMurry, A.; Weber, G.; MacFadden, D.; Rappaport, L.; Kunkel, L.; Bickel, J.; Wattanasin, N.; Spence, S.; Murphy, S.; Churchill, S. The co-morbidity burden of children and young adults with autism spectrum disorders. PLoS One, 2012, 7(4), e33224.
[http://dx.doi.org/10.1371/journal.pone.0033224] [PMID: 22511918]
[52]
Fox-Edmiston, E.; Van de Water, J. Maternal anti-fetal brain igg autoantibodies and autism spectrum disorder: Current knowledge and its implications for potential therapeutics. CNS Drugs, 2015, 29(9), 715-724.
[http://dx.doi.org/10.1007/s40263-015-0279-2] [PMID: 26369920]
[53]
Brown, A.S.; Surcel, H.M.; Hinkka-Yli-Salomäki, S.; Cheslack-Postava, K.; Bao, Y.; Sourander, A. Maternal thyroid autoantibody and elevated risk of autism in a national birth cohort. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2015, 57, 86-92.
[http://dx.doi.org/10.1016/j.pnpbp.2014.10.010] [PMID: 25445476]
[54]
Zerbo, O.; Traglia, M.; Yoshida, C.; Heuer, L.S.; Ashwood, P.; Delorenze, G.N.; Hansen, R.L.; Kharrazi, M.; Van de Water, J.; Yolken, R.H.; Weiss, L.A.; Croen, L.A. Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study. Transl. Psychiatry, 2016, 6(4), e783.
[http://dx.doi.org/10.1038/tp.2016.46] [PMID: 27093065]
[55]
Abdallah, M.W.; Larsen, N.; Mortensen, E.L.; Atladóttir, H.Ó.; Nørgaard-Pedersen, B.; Bonefeld-Jørgensen, E.C.; Grove, J.; Hougaard, D.M. Neonatal levels of cytokines and risk of autism spectrum disorders: An exploratory register-based historic birth cohort study utilizing the Danish Newborn Screening Biobank. J. Neuroimmunol., 2012, 252(1-2), 75-82.
[http://dx.doi.org/10.1016/j.jneuroim.2012.07.013] [PMID: 22917523]
[56]
Krakowiak, P.; Goines, P.E.; Tancredi, D.J.; Ashwood, P.; Hansen, R.L.; Hertz-Picciotto, I.; Van de Water, J. Neonatal cytokine profiles associated with autism spectrum disorder. Biol. Psychiatry, 2017, 81(5), 442-451.
[http://dx.doi.org/10.1016/j.biopsych.2015.08.007] [PMID: 26392128]
[57]
Newschaffer, C.J.; Croen, L.A.; Daniels, J.; Giarelli, E.; Grether, J.K.; Levy, S.E.; Mandell, D.S.; Miller, L.A.; Pinto-Martin, J.; Reaven, J.; Reynolds, A.M.; Rice, C.E.; Schendel, D.; Windham, G.C. The epidemiology of autism spectrum disorders. Annu. Rev. Public Health, 2007, 28(1), 235-258.
[http://dx.doi.org/10.1146/annurev.publhealth.28.021406.144007] [PMID: 17367287]
[58]
Borue, X.; Chen, J.; Condron, B.G. Developmental effects of SSRIs: Lessons learned from animal studies. Int. J. Dev. Neurosci., 2007, 25(6), 341-347.
[http://dx.doi.org/10.1016/j.ijdevneu.2007.06.003] [PMID: 17706396]
[59]
Bercum, F.M.; Rodgers, K.M.; Benison, A.M.; Smith, Z.Z.; Taylor, J.; Kornreich, E.; Grabenstatter, H.L.; Dudek, F.E.; Barth, D.S. Maternal stress combined with terbutaline leads to comorbid autistic-like behavior and epilepsy in a rat model. J. Neurosci., 2015, 35(48), 15894-15902.
[http://dx.doi.org/10.1523/JNEUROSCI.2803-15.2015] [PMID: 26631470]
[60]
Christensen, J.; Grønborg, T.K.; Sørensen, M.J.; Schendel, D.; Parner, E.T.; Pedersen, L.H.; Vestergaard, M. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA, 2013, 309(16), 1696-1703.
[http://dx.doi.org/10.1001/jama.2013.2270] [PMID: 23613074]
[61]
Bromley, R.L.; Mawer, G.E.; Briggs, M.; Cheyne, C.; Clayton-Smith, J.; García-Fiñana, M.; Kneen, R.; Lucas, S.B.; Shallcross, R.; Baker, G.A.; Baker, G.; Briggs, M.; Bromley, R.; Clayton-Smith, J.; Dixon, P.; Fryer, A.; Gummery, A.; Kneen, R.; Kerr, L.; Lucas, S.; Mawer, G.; Shallcross, R. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J. Neurol. Neurosurg. Psychiatry, 2013, 84(6), 637-643.
[http://dx.doi.org/10.1136/jnnp-2012-304270] [PMID: 23370617]
[62]
Veiby, G.; Daltveit, A.K.; Schjølberg, S.; Stoltenberg, C.; Øyen, A.S.; Vollset, S.E.; Engelsen, B.A.; Gilhus, N.E. Exposure to antiepileptic drugs in utero and child development: A prospective population-based study. Epilepsia, 2013, 54(8), 1462-1472.
[http://dx.doi.org/10.1111/epi.12226] [PMID: 23865818]
[63]
Gidaya, N.B.; Lee, B.K.; Burstyn, I.; Michael, Y.; Newschaffer, C.J.; Mortensen, E.L. In utero exposure to β-2-adrenergic receptor agonist drugs and risk for autism spectrum disorders. Pediatrics, 2016, 137(2), e20151316-e20151316.
[http://dx.doi.org/10.1542/peds.2015-1316] [PMID: 26738885]
[64]
Moore, G.S.; Kneitel, A.W.; Walker, C.K.; Gilbert, W.M.; Xing, G. Autism risk in small- and large-for-gestational-age infants. Am. J. Obstet. Gynecol., 2012, 206(4), 314.e1-314.e9.
[http://dx.doi.org/10.1016/j.ajog.2012.01.044] [PMID: 22464070]
[65]
Leavey, A.; Zwaigenbaum, L.; Heavner, K.; Burstyn, I. Gestational age at birth and risk of autism spectrum disorders in Alberta, Canada. J. Pediatr., 2013, 162(2), 361-368.
[http://dx.doi.org/10.1016/j.jpeds.2012.07.040] [PMID: 22947654]
[66]
Abel, K.M.; Dalman, C.; Svensson, A.C.; Susser, E.; Dal, H.; Idring, S.; Webb, R.T.; Rai, D.; Magnusson, C. Deviance in fetal growth and risk of autism spectrum disorder. Am. J. Psychiatry, 2013, 170(4), 391-398.
[http://dx.doi.org/10.1176/appi.ajp.2012.12040543] [PMID: 23545793]
[67]
Walker, C.K.; Krakowiak, P.; Baker, A.; Hansen, R.L.; Ozonoff, S.; Hertz-Picciotto, I. Preeclampsia, placental insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatr., 2015, 169(2), 154-162.
[http://dx.doi.org/10.1001/jamapediatrics.2014.2645] [PMID: 25485869]
[68]
Krakowiak, P.; Walker, C.K.; Bremer, A.A.; Baker, A.S.; Ozonoff, S.; Hansen, R.L.; Hertz-Picciotto, I. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics, 2012, 129(5), e1121-e1128.
[http://dx.doi.org/10.1542/peds.2011-2583] [PMID: 22492772]
[69]
Li, Y.M.; Ou, J.J.; Liu, L.; Zhang, D.; Zhao, J.P.; Tang, S.Y. Association between maternal obesity and autism spectrum disorder in offspring: A meta-analysis. J. Autism Dev. Disord., 2016, 46(1), 95-102.
[http://dx.doi.org/10.1007/s10803-015-2549-8] [PMID: 26254893]
[70]
Li, M.; Fallin, M.D.; Riley, A.; Landa, R.; Walker, S.O.; Silverstein, M.; Caruso, D.; Pearson, C.; Kiang, S.; Dahm, J.L.; Hong, X.; Wang, G.; Wang, M.C.; Zuckerman, B.; Wang, X. The association of maternal obesity and diabetes with autism and other developmental disabilities. Pediatrics, 2016, 137(2), e20152206.
[http://dx.doi.org/10.1542/peds.2015-2206] [PMID: 26826214]
[71]
Smallwood, M.; Sareen, A.; Baker, E.; Hannusch, R.; Kwessi, E.; Williams, T. Increased risk of autism development in children whose mothers experienced birth complications or received labor and delivery drugs. ASN Neuro, 2016, 8(4)
[http://dx.doi.org/10.1177/1759091416659742] [PMID: 27511908]
[72]
Glasson, E.J.; Bower, C.; Petterson, B.; de Klerk, N.; Chaney, G.; Hallmayer, J.F. Perinatal factors and the development of autism: A population study. Arch. Gen. Psychiatry, 2004, 61(6), 618-627.
[http://dx.doi.org/10.1001/archpsyc.61.6.618] [PMID: 15184241]
[73]
Wahl, R.U.R. Could oxytocin administration during labor contribute to autism and related behavioral disorders? – A look at the literature. Med. Hypotheses, 2004, 63(3), 456-460.
[http://dx.doi.org/10.1016/j.mehy.2004.03.008] [PMID: 15288368]
[74]
Curran, E.A.; Dalman, C.; Kearney, P.M.; Kenny, L.C.; Cryan, J.F.; Dinan, T.G.; Khashan, A.S. Association between obstetric mode of delivery and autism spectrum disorder. JAMA Psychiatry, 2015, 72(9), 935-942.
[http://dx.doi.org/10.1001/jamapsychiatry.2015.0846] [PMID: 26107922]
[75]
Curran, E.A.; Cryan, J.F.; Kenny, L.C.; Dinan, T.G.; Kearney, P.M.; Khashan, A.S. Obstetrical mode of delivery and childhood behavior and psychological development in a british cohort. J. Autism Dev. Disord., 2016, 46(2), 603-614.
[http://dx.doi.org/10.1007/s10803-015-2616-1] [PMID: 26412364]
[76]
Curran, E.A.; O’Neill, S.M.; Cryan, J.F.; Kenny, L.C.; Dinan, T.G.; Khashan, A.S.; Kearney, P.M. Research Review: Birth by caesarean section and development of autism spectrum disorder and attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. J. Child Psychol. Psychiatry, 2015, 56(5), 500-508.
[http://dx.doi.org/10.1111/jcpp.12351] [PMID: 25348074]
[77]
Nagano, M.; Saitow, F.; Higo, S.; Uzuki, M.; Mikahara, Y.; Akimoto, T.; Ozawa, H.; Nishimori, K.; Suzuki, H. Cesarean section delivery is a risk factor of autism-related behaviors in mice. Sci. Rep., 2021, 11(1), 8883.
[http://dx.doi.org/10.1038/s41598-021-88437-8] [PMID: 33903690]
[78]
Yip, B.H.K.; Leonard, H.; Stock, S.; Stoltenberg, C.; Francis, R.W.; Gissler, M.; Gross, R.; Schendel, D.; Sandin, S. Caesarean section and risk of autism across gestational age: A multi-national cohort study of 5 million births. Int. J. Epidemiol., 2016, 46(2), dyw336.
[http://dx.doi.org/10.1093/ije/dyw336] [PMID: 28017932]
[79]
Lyall, K.; Baker, A.; Hertz-Picciotto, I.; Walker, C. Infertility and its treatments in association with autism spectrum disorders: A review and results from the CHARGE study. Int. J. Environ. Res. Public Health, 2013, 10(8), 3715-3734.
[http://dx.doi.org/10.3390/ijerph10083715] [PMID: 23965925]
[80]
Fountain, C.; Zhang, Y.; Kissin, D.M.; Schieve, L.A.; Jamieson, D.J.; Rice, C.; Bearman, P. Association between assisted reproductive technology conception and autism in California, 1997-2007. Am. J. Public Health, 2015, 105(5), 963-971.
[http://dx.doi.org/10.2105/AJPH.2014.302383] [PMID: 25790396]
[81]
Bay, B.; Mortensen, E.L.; Hvidtjørn, D.; Kesmodel, U.S. Fertility treatment and risk of childhood and adolescent mental disorders: register based cohort study. BMJ, 2013, 347(jul05 1), f3978-f3978.
[http://dx.doi.org/10.1136/bmj.f3978] [PMID: 23833075]
[82]
Hvidtjørn, D.; Grove, J.; Schendel, D.; Schieve, L.A.; Svaerke, C.; Ernst, E.; Thorsen, P. Risk of autism spectrum disorders in children born after assisted conception: A population-based follow-up study. J. Epidemiol. Community Health, 2011, 65(6), 497-502.
[http://dx.doi.org/10.1136/jech.2009.093823] [PMID: 20584728]
[83]
Sandin, S.; Nygren, K.G.; Iliadou, A.; Hultman, C.M.; Reichenberg, A. Autism and mental retardation among offspring born after in vitro fertilization. JAMA, 2013, 310(1), 75-84.
[http://dx.doi.org/10.1001/jama.2013.7222] [PMID: 23821091]
[84]
Schieve, L.A.; Fountain, C.; Boulet, S.L.; Yeargin-Allsopp, M.; Kissin, D.M.; Jamieson, D.J.; Rice, C.; Bearman, P. Does autism diagnosis age or symptom severity differ among children according to whether assisted reproductive technology was used to achieve pregnancy? J. Autism Dev. Disord., 2015, 45(9), 2991-3003.
[http://dx.doi.org/10.1007/s10803-015-2462-1] [PMID: 25997596]
[85]
Maureen, M. Black. Effects of vitamin B 12 and folate deficiency on brain development in children. Food Nutr. Bull., 2008.
[86]
Bjørklund, G. The role of zinc and copper in autism spectrum disorders. Acta Neurobiol. Exp., 2013, 73(2), 225-236.
[PMID: 23823984]
[87]
Skalny, A.V.; Mazaletskaya, A.L.; Ajsuvakova, O.P.; Bjørklund, G.; Skalnaya, M.G.; Chernova, L.N.; Skalny, A.A.; Tinkov, A.A. Magnesium status in children with attention-deficit/hyperactivity disorder and/or autism spectrum disorder. J. Korean Acad. Child Adolesc. Psychiatry, 2020, 31(1), 41-45.
[http://dx.doi.org/10.5765/jkacap.190036] [PMID: 32612412]
[88]
Skalny, A.V.; Skalnaya, M.G.; Bjørklund, G.; Gritsenko, V.A.; Aaseth, J.; Tinkov, A.A. Selenium and autism spectrum disorder. In: Selenium; Springer: Cham, 2018.
[http://dx.doi.org/10.1007/978-3-319-95390-8_10]
[89]
Awadh, S.M.; Yaseen, Z.M.; Al-Suwaiyan, M.S. The role of environmental trace element toxicants on autism: A medical biogeochemistry perspective. Ecotoxicol. Environ. Saf., 2023, 251, 114561.
[http://dx.doi.org/10.1016/j.ecoenv.2023.114561] [PMID: 36696851]
[90]
Surén, P.; Roth, C.; Bresnahan, M.; Haugen, M.; Hornig, M.; Hirtz, D.; Lie, K. K.; Lipkin, W. I.; Reichborn-Kjennerud, T.; Schjølberg, S. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA, 2013, 309(6), 570-577.
[91]
Schmidt, R.J.; Hansen, R.L.; Hartiala, J.; Allayee, H.; Schmidt, L.C.; Tancredi, D.J.; Tassone, F.; Hertz-Picciotto, I. Prenatal vitamins, one-carbon metabolism gene variants, and risk for autism. Epidemiology, 2011, 22(4), 476-485.
[http://dx.doi.org/10.1097/EDE.0b013e31821d0e30] [PMID: 21610500]
[92]
Schmidt, R.J.; Tancredi, D.J.; Ozonoff, S.; Hansen, R.L.; Hartiala, J.; Allayee, H.; Schmidt, L.C.; Tassone, F.; Hertz-Picciotto, I. Maternal periconceptional folic acid intake and risk for developmental delay and autism spectrum disorder: A case-control study. Am. J. Clin. Nutr., 2012, 2012, 004416.
[http://dx.doi.org/10.3945/ajcn.110.004416] [PMID: 22648721]
[93]
Virk, J.; Liew, Z.; Olsen, J.; Nohr, E.A.; Catov, J.M.; Ritz, B. Preconceptional and prenatal supplementary folic acid and multivitamin intake and autism spectrum disorders. Autism, 2016, 20(6), 710-718.
[http://dx.doi.org/10.1177/1362361315604076] [PMID: 26408631]
[94]
Crider, K.S.; Bailey, L.B.; Berry, R.J. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients, 2011, 3(3), 370-384.
[http://dx.doi.org/10.3390/nu3030370] [PMID: 22254102]
[95]
Whitehouse, A.J.O.; Holt, B.J.; Serralha, M.; Holt, P.G.; Hart, P.H.; Kusel, M.M.H. Maternal vitamin D levels and the autism phenotype among offspring. J. Autism Dev. Disord., 2013, 43(7), 1495-1504.
[http://dx.doi.org/10.1007/s10803-012-1676-8] [PMID: 23070790]
[96]
Zhong, C.; Tessing, J.; Lee, B.K.; Lyall, K. Maternal dietary factors and the risk of autism spectrum disorders: A systematic review of existing evidence. Autism Res., 2020, 13(10), 1634-1658.
[http://dx.doi.org/10.1002/aur.2402] [PMID: 33015977]
[97]
Saad, K.; Abdel-rahman, A.A.; Elserogy, Y.M.; Al-Atram, A.A.; Cannell, J.J.; Bjørklund, G.; Abdel-Reheim, M.K.; Othman, H.A.K.; El-Houfey, A.A.; Abd El-Aziz, N.H.R.; Abd El-Baseer, K.A.; Ahmed, A.E.; Ali, A.M. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children. Nutr. Neurosci., 2016, 19(8), 346-351.
[http://dx.doi.org/10.1179/1476830515Y.0000000019] [PMID: 25876214]
[98]
Lyall, K.; Munger, K.L.; O’Reilly, É.J.; Santangelo, S.L.; Ascherio, A. Maternal dietary fat intake in association with autism spectrum disorders. Am. J. Epidemiol., 2013, 178(2), 209-220.
[http://dx.doi.org/10.1093/aje/kws433] [PMID: 23813699]
[99]
Gallagher, C.; McCarthy, F.P.; Ryan, R.M.; Khashan, A.S. Maternal alcohol consumption during pregnancy and the risk of autism spectrum disorders in offspring: A retrospective analysis of the millennium cohort study. J. Autism Dev. Disord., 2018, 48(11), 3773-3782.
[http://dx.doi.org/10.1007/s10803-018-3626-6] [PMID: 29948531]
[100]
Rosen, B.N.; Lee, B.K.; Lee, N.L.; Yang, Y.; Burstyn, I. Maternal smoking and autism spectrum disorder: A meta-analysis. J. Autism Dev. Disord., 2015, 45(6), 1689-1698.
[http://dx.doi.org/10.1007/s10803-014-2327-z] [PMID: 25432101]
[101]
Eliasen, M.; Tolstrup, J.S.; Nybo Andersen, A.M.; Grønbaek, M.; Olsen, J.; Strandberg-Larsen, K. Prenatal alcohol exposure and autistic spectrum disorders--a population-based prospective study of 80 552 children and their mothers. Int. J. Epidemiol., 2010, 39(4), 1074-1081.
[http://dx.doi.org/10.1093/ije/dyq056] [PMID: 20371506]
[102]
Hertz-Picciotto, I.; Korrick, S.A.; Ladd-Acosta, C.; Karagas, M.R.; Lyall, K.; Schmidt, R.J.; Dunlop, A.L.; Croen, L.A.; Dabelea, D.; Daniels, J.L.; Duarte, C.S.; Fallin, M.D.; Karr, C.J.; Lester, B.; Leve, L.D.; Li, Y.; McGrath, M.; Ning, X.; Oken, E.; Sagiv, S.K.; Sathyanaraya, S.; Tylavsky, F.; Volk, H.E.; Wakschlag, L.S.; Zhang, M.; O’Shea, T.M.; Musci, R.J. Maternal tobacco smoking and offspring autism spectrum disorder or traits in ECHO cohorts. Autism Res., 2022, 15(3), 551-569.
[http://dx.doi.org/10.1002/aur.2665] [PMID: 35199959]
[103]
Kern, J.K.; Geier, D.A.; Homme, K.G.; King, P.G.; Bjørklund, G.; Chirumbolo, S.; Geier, M.R. Developmental neurotoxicants and the vulnerable male brain: a systematic review of suspected neurotoxicants that disproportionally affect males. Acta Neurobiol. Exp., 2017, 77(4), 269-296.
[http://dx.doi.org/10.21307/ane-2017-061] [PMID: 29369294]
[104]
Becerra, T.A.; Wilhelm, M.; Olsen, J.; Cockburn, M.; Ritz, B. Ambient air pollution and autism in Los Angeles county, California. Environ. Health Perspect., 2013, 121(3), 380-386.
[http://dx.doi.org/10.1289/ehp.1205827] [PMID: 23249813]
[105]
Kalkbrenner, A.E.; Windham, G.C.; Serre, M.L.; Akita, Y.; Wang, X.; Hoffman, K.; Thayer, B.P.; Daniels, J.L. Particulate matter exposure, prenatal and postnatal windows of susceptibility, and autism spectrum disorders. Epidemiology, 2015, 26(1), 30-42.
[http://dx.doi.org/10.1097/EDE.0000000000000173] [PMID: 25286049]
[106]
Kalkbrenner, A.E.; Daniels, J.L.; Chen, J.C.; Poole, C.; Emch, M.; Morrissey, J. Perinatal exposure to hazardous air pollutants and autism spectrum disorders at age 8. Epidemiology, 2010, 21(5), 631-641.
[http://dx.doi.org/10.1097/EDE.0b013e3181e65d76] [PMID: 20562626]
[107]
Roberts, A.L.; Lyall, K.; Hart, J.E.; Laden, F.; Just, A.C.; Bobb, J.F.; Koenen, K.C.; Ascherio, A.; Weisskopf, M.G. Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses’ Health Study II participants. Environ. Health Perspect., 2013, 121(8), 978-984.
[http://dx.doi.org/10.1289/ehp.1206187] [PMID: 23816781]
[108]
Talbott, E.O.; Arena, V.C.; Rager, J.R.; Clougherty, J.E.; Michanowicz, D.R.; Sharma, R.K.; Stacy, S.L. Fine particulate matter and the risk of autism spectrum disorder. Environ. Res., 2015, 140, 414-420.
[http://dx.doi.org/10.1016/j.envres.2015.04.021] [PMID: 25957837]
[109]
Talbott, E. O.; Marshall, L. P.; Rager, J. R.; Arena, V. C.; Sharma, R. K.; Stacy, S. L. Air toxics and the risk of autism spectrum disorder: The results of a population based case-control study in Southwestern Pennsylvania. Environ. Health, 2015, 14, 80.
[http://dx.doi.org/10.1186/s12940-015-0064-1]
[110]
Volk, H.E.; Lurmann, F.; Penfold, B.; Hertz-Picciotto, I.; McConnell, R. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry, 2013, 70(1), 71-77.
[http://dx.doi.org/10.1001/jamapsychiatry.2013.266] [PMID: 23404082]
[111]
Volk, H.E.; Hertz-Picciotto, I.; Delwiche, L.; Lurmann, F.; McConnell, R. Residential proximity to freeways and autism in the CHARGE study. Environ. Health Perspect., 2011, 119(6), 873-877.
[http://dx.doi.org/10.1289/ehp.1002835] [PMID: 21156395]
[112]
von Ehrenstein, O.S.; Aralis, H.; Cockburn, M.; Ritz, B. In utero exposure to toxic air pollutants and risk of childhood autism. Epidemiology, 2014, 25(6), 851-858.
[http://dx.doi.org/10.1097/EDE.0000000000000150] [PMID: 25051312]
[113]
Windham, G.C.; Zhang, L.; Gunier, R.; Croen, L.A.; Grether, J.K. Autism spectrum disorders in relation to distribution of hazardous air pollutants in the san francisco bay area. Environ. Health Perspect., 2006, 114(9), 1438-1444.
[http://dx.doi.org/10.1289/ehp.9120] [PMID: 16966102]
[114]
Raz, R.; Roberts, A.L.; Lyall, K.; Hart, J.E.; Just, A.C.; Laden, F.; Weisskopf, M.G. Autism spectrum disorder and particulate matter air pollution before, during, and after pregnancy: A nested case–control analysis within the nurses’ health study II cohort. Environ. Health Perspect., 2015, 123(3), 264-270.
[http://dx.doi.org/10.1289/ehp.1408133]
[115]
Volk, H.E.; Kerin, T.; Lurmann, F.; Hertz-Picciotto, I.; McConnell, R.; Campbell, D.B. Autism spectrum disorder. Epidemiology, 2014, 25(1), 44-47.
[http://dx.doi.org/10.1097/EDE.0000000000000030] [PMID: 24240654]
[116]
Guxens, M.; Ghassabian, A.; Gong, T.; Garcia-Esteban, R.; Porta, D.; Giorgis-Allemand, L.; Almqvist, C.; Aranbarri, A.; Beelen, R.; Badaloni, C.; Cesaroni, G.; de Nazelle, A.; Estarlich, M.; Forastiere, F.; Forns, J.; Gehring, U.; Ibarluzea, J.; Jaddoe, V.W.V.; Korek, M.; Lichtenstein, P.; Nieuwenhuijsen, M.J.; Rebagliato, M.; Slama, R.; Tiemeier, H.; Verhulst, F.C.; Volk, H.E.; Pershagen, G.; Brunekreef, B.; Sunyer, J. Air pollution exposure during pregnancy and childhood autistic traits in four european population-based cohort studies: The ESCAPE project. Environ. Health Perspect., 2016, 124(1), 133-140.
[http://dx.doi.org/10.1289/ehp.1408483] [PMID: 26068947]
[117]
Gong, T.; Almqvist, C.; Bölte, S.; Lichtenstein, P.; Anckarsäter, H.; Lind, T.; Lundholm, C.; Pershagen, G. Exposure to air pollution from traffic and neurodevelopmental disorders in Swedish twins. Twin Res. Human genet., 2014, 17(6)
[http://dx.doi.org/10.1017/thg.2014.58]
[118]
Jung, C.R.; Lin, Y.T.; Hwang, B.F. Air pollution and newly diagnostic autism spectrum disorders: A population-based cohort study in Taiwan. PLoS One, 2013, 8(9), e75510-e75510.
[http://dx.doi.org/10.1371/journal.pone.0075510] [PMID: 24086549]
[119]
Weisskopf, M.G.; Kioumourtzoglou, M.A.; Roberts, A.L. Air pollution and autism spectrum disorders: Causal or confounded? Curr. Environ. Health Rep., 2015, 2(4), 430-439.
[http://dx.doi.org/10.1007/s40572-015-0073-9] [PMID: 26399256]
[120]
Suades-González, E.; Gascon, M.; Guxens, M.; Sunyer, J. Air pollution and neuropsychological development: A review of the latest evidence. Endocrinology, 2015, 156(10), 3473-3482.
[http://dx.doi.org/10.1210/en.2015-1403] [PMID: 26241071]
[121]
Schug, T.T.; Blawas, A.M.; Gray, K.; Heindel, J.J.; Lawler, C.P. Elucidating the links between endocrine disruptors and neurodevelopment. Endocrinology, 2015, 156(6), 1941-1951.
[http://dx.doi.org/10.1210/en.2014-1734] [PMID: 25714811]
[122]
Grandjean, P.; Landrigan, P.J. Neurobehavioural effects of developmental toxicity. Lancet Neurol., 2014, 13(3), 330-338.
[http://dx.doi.org/10.1016/S1474-4422(13)70278-3] [PMID: 24556010]
[123]
Woodruff, T.J.; Zota, A.R.; Schwartz, J.M. Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environ. Health Perspect., 2011, 119(6), 878-885.
[http://dx.doi.org/10.1289/ehp.1002727] [PMID: 21233055]
[124]
Eskenazi, B.; Marks, A.R.; Bradman, A.; Harley, K.; Barr, D.B.; Johnson, C.; Morga, N.; Jewell, N.P. Organophosphate pesticide exposure and neurodevelopment in young Mexican-American children. Environ. Health Perspect., 2007, 115(5), 792-798.
[http://dx.doi.org/10.1289/ehp.9828] [PMID: 17520070]
[125]
Braun, J.M.; Kalkbrenner, A.E.; Just, A.C.; Yolton, K.; Calafat, A.M.; Sjödin, A.; Hauser, R.; Webster, G.M.; Chen, A.; Lanphear, B.P. Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: the HOME study. Environ. Health Perspect., 2014, 122(5), 513-520.
[http://dx.doi.org/10.1289/ehp.1307261] [PMID: 24622245]
[126]
Lyall, K.; Croen, L.A.; Sjödin, A.; Yoshida, C.K.; Zerbo, O.; Kharrazi, M.; Windham, G.C. Polychlorinated biphenyl and organochlorine pesticide concentrations in maternal mid-pregnancy serum samples: Association with autism spectrum disorder and intellectual disability. Environ. Health Perspect., 2017, 125(3), 474-480.
[http://dx.doi.org/10.1289/EHP277] [PMID: 27548254]
[127]
Roberts, E.M.; English, P.B.; Grether, J.K.; Windham, G.C.; Somberg, L.; Wolff, C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ. Health Perspect., 2007, 115(10), 1482-1489.
[http://dx.doi.org/10.1289/ehp.10168] [PMID: 17938740]
[128]
Shelton, J.F.; Geraghty, E.M.; Tancredi, D.J.; Delwiche, L.D.; Schmidt, R.J.; Ritz, B.; Hansen, R.L.; Hertz-Picciotto, I. Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: The CHARGE study. Environ. Health Perspect., 2014, 122(10), 1103-1109.
[http://dx.doi.org/10.1289/ehp.1307044] [PMID: 24954055]
[129]
Cheslack-Postava, K.; Rantakokko, P. V.; Hinkka-Yli-Salomäki, S.; Surcel, H.-M.; McKeague, I. W.; Kiviranta, H. A.; Sourander, A.; Brown, A. S. Maternal serum persistent organic pollutants in the finnish prenatal study of autism: A pilot study. Neurotoxicol. Teratol., 2013, 38, 1-5.
[http://dx.doi.org/10.1016/j.ntt.2013.04.001]
[130]
Miodovnik, A.; Engel, S.M.; Zhu, C.; Ye, X.; Soorya, L.V.; Silva, M.J.; Calafat, A.M.; Wolff, M.S. Endocrine disruptors and childhood social impairment. Neurotoxicology, 2011, 32(2), 261-267.
[http://dx.doi.org/10.1016/j.neuro.2010.12.009] [PMID: 21182865]
[131]
Liew, Z.; Ritz, B.; von Ehrenstein, O.S.; Bech, B.H.; Nohr, E.A.; Fei, C.; Bossi, R.; Henriksen, T.B.; Bonefeld-Jørgensen, E.C.; Olsen, J. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: A nested case-control study in the Danish National Birth Cohort. Environ. Health Perspect., 2015, 123(4), 367-373.
[http://dx.doi.org/10.1289/ehp.1408412] [PMID: 25616253]
[132]
Bjørklund, G.; Skalny, A.V.; Rahman, M.M.; Dadar, M.; Yassa, H.A.; Aaseth, J.; Chirumbolo, S.; Skalnaya, M.G.; Tinkov, A.A. Toxic metal(loid)-based pollutants and their possible role in autism spectrum disorder. Environ. Res., 2018, 166, 234-250.
[http://dx.doi.org/10.1016/j.envres.2018.05.020] [PMID: 29902778]
[133]
Kortenkamp, A. Are cadmium and other heavy metal compounds acting as endocrine disrupters? Met. Ions Life Sci., 2011, 8, 305-317.
[PMID: 21473385]
[134]
Harutyunyan, A.A.; Harutyunyan, H.A.; Yenkoyan, K.B. Novel probable glance at inflammatory scenario development in autistic pathology. Front. Psychiatry, 2021, 12, 788779.
[http://dx.doi.org/10.3389/fpsyt.2021.788779] [PMID: 35002805]
[135]
Mostafa, G.A.; Bjørklund, G.; Urbina, M.A.; Al-Ayadhi, L.Y. The positive association between elevated blood lead levels and brain-specific autoantibodies in autistic children from low lead-polluted areas. Metab. Brain Dis., 2016, 31(5), 1047-1054.
[http://dx.doi.org/10.1007/s11011-016-9836-8] [PMID: 27250967]
[136]
Mohammadabadi, H. J.; Rahmatian, A.; Sayehmiri, F.; Rafiei, M. The relationship between the level of copper, lead, mercury and autism disorders: A meta-analysis. PHMT, 2020, 11, 369-378.
[http://dx.doi.org/10.2147/PHMT.S210042]
[137]
Bjørklund, G. Selenium as an antidote in the treatment of mercury intoxication. Biometals, 2015, 28(4), 605-614.
[http://dx.doi.org/10.1007/s10534-015-9857-5] [PMID: 25947386]
[138]
Bjørklund, G.; Aaseth, J.; Ajsuvakova, O.P.; Nikonorov, A.A.; Skalny, A.V.; Skalnaya, M.G.; Tinkov, A.A. Molecular interaction between mercury and selenium in neurotoxicity. Coord. Chem. Rev., 2017, 332, 30-37.
[http://dx.doi.org/10.1016/j.ccr.2016.10.009]
[139]
El-Ansary, A.; Bjørklund, G.; Tinkov, A.A.; Skalny, A.V.; Al Dera, H. Relationship between selenium, lead, and mercury in red blood cells of Saudi autistic children. Metab. Brain Dis., 2017, 32(4), 1073-1080.
[http://dx.doi.org/10.1007/s11011-017-9996-1] [PMID: 28326463]
[140]
Sulaiman, R.; Wang, M.; Ren, X. Exposure to aluminum, cadmium, and mercury and autism spectrum disorder in children: A systematic review and meta-analysis. Chem. Res. Toxicol., 2020, 33(11), 2699-2718.
[http://dx.doi.org/10.1021/acs.chemrestox.0c00167] [PMID: 32990432]
[141]
Hurley, A.M.; Tadrous, M.; Miller, E.S. Thimerosal-containing vaccines and autism: A review of recent epidemiologic studies. J. Pediatr. Pharmacol. Ther., 2010, 15(3), 173-181.
[http://dx.doi.org/10.5863/1551-6776-15.3.173] [PMID: 22477809]
[142]
Immunization Safety Review Committee. Immunization Safety Review: Vaccines and Autism; National Academies Press: Washington (DC), 2004.
[143]
Committee on the Assessment of Studies of Health Outcomes Related to the Recommended Childhood Immunization Schedule. The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies; National Academies Press: Washington (DC), 2015.
[http://dx.doi.org/10.17226/13563]
[144]
Stratton, K.; Ford, A.; Rusch, E.; Clayton, E. W.; Vaccines, C. Adverse Effects of Vaccines: Evidence and Causality; National Academies Press: Washington (DC), 2011.
[http://dx.doi.org/10.17226/13164]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy